| Key chemokines direct migration of immune cells in solid tumors K Kohli, VG Pillarisetty, TS Kim Cancer gene therapy 29 (1), 10-21, 2022 | 388 | 2022 |
| Cell type-specific effects of Rb deletion in the murine retina D MacPherson, J Sage, T Kim, D Ho, ME McLaughlin, T Jacks Genes & development 18 (14), 1681-1694, 2004 | 272 | 2004 |
| Clinical implications of detection of Ureaplasma urealyticum in the amniotic cavity with the polymerase chain reaction BH Yoon, R Romero, M Kim, EC Kim, T Kim, JS Park, JK Jun American journal of obstetrics and gynecology 183 (5), 1130-1137, 2000 | 245 | 2000 |
| RETRACTED: CD44 Expression Denotes a Subpopulation of Gastric Cancer Cells in Which Hedgehog Signaling Promotes Chemotherapy Resistance C Yoon, DJ Park, B Schmidt, NJ Thomas, HJ Lee, TS Kim, YY Janjigian, ... Clinical cancer research 20 (15), 3974-3988, 2014 | 217 | 2014 |
| Age-specific incidence of melanoma in the United States KG Paulson, D Gupta, TS Kim, JR Veatch, DR Byrd, S Bhatia, K Wojcik, ... JAMA dermatology 156 (1), 57-64, 2020 | 216 | 2020 |
| Mobilization of CD8+ T Cells via CXCR4 Blockade Facilitates PD-1 Checkpoint Therapy in Human Pancreatic Cancer YD Seo, X Jiang, KM Sullivan, FG Jalikis, KS Smythe, A Abbasi, M Vignali, ... Clinical Cancer Research 25 (13), 3934-3945, 2019 | 203 | 2019 |
| Defective apoptosis and B‐cell lymphomas in mice with p53 point mutation at Ser 23 D MacPherson, J Kim, T Kim, BK Rhee, CTM van Oostrom, RA DiTullio Jr, ... The EMBO journal 23 (18), 3689-3699, 2004 | 153 | 2004 |
| PD-1/PD-L1 blockade enhances T-cell activity and antitumor efficacy of imatinib in gastrointestinal stromal tumors AM Seifert, S Zeng, JQ Zhang, TS Kim, NA Cohen, MJ Beckman, ... Clinical Cancer Research 23 (2), 454-465, 2017 | 149 | 2017 |
| KIT oncogene inhibition drives intratumoral macrophage M2 polarization MJ Cavnar, S Zeng, TS Kim, EC Sorenson, LM Ocuin, VP Balachandran, ... Journal of Experimental Medicine 210 (13), 2873-2886, 2013 | 146 | 2013 |
| Neoantigen-specific CD4+ T cells in human melanoma have diverse differentiation states and correlate with CD8+ T cell, macrophage, and B cell function JR Veatch, SM Lee, C Shasha, N Singhi, JL Szeto, AS Moshiri, TS Kim, ... Cancer Cell 40 (4), 393-409. e9, 2022 | 101 | 2022 |
| Blockade of interleukin 10 potentiates antitumour immune function in human colorectal cancer liver metastases KM Sullivan, X Jiang, P Guha, C Lausted, JA Carter, C Hsu, KP Labadie, ... Gut 72 (2), 325-337, 2023 | 97 | 2023 |
| Mutational analyses of RB and BRCA2 as candidate tumour suppressor genes in parathyroid carcinoma TM Shattuck, TS Kim, J Costa, DW Yandell, Y Imanishi, N Palanisamy, ... Clinical endocrinology 59 (2), 180-189, 2003 | 95 | 2003 |
| Combining targeted therapy and immune checkpoint inhibitors in the treatment of metastatic melanoma K Teresa, RN Amaria, C Spencer, A Reuben, ZA Cooper, JA Wargo Cancer biology & medicine 11 (4), 237-246, 2014 | 94 | 2014 |
| Intratumoral immune response to gastric cancer varies by molecular and histologic subtype TS Kim, E da Silva, DG Coit, LH Tang The American journal of surgical pathology 43 (6), 851-860, 2019 | 67 | 2019 |
| Pharmacological inhibition of KIT activates MET signaling in gastrointestinal stromal tumors NA Cohen, S Zeng, AM Seifert, TS Kim, EC Sorenson, JB Greer, ... Cancer research 75 (10), 2061-2070, 2015 | 66 | 2015 |
| Nilotinib protects the murine liver from ischemia/reperfusion injury LM Ocuin, S Zeng, MJ Cavnar, EC Sorenson, ZM Bamboat, JB Greer, ... Journal of hepatology 57 (4), 766-773, 2012 | 64 | 2012 |
| Increased KIT inhibition enhances therapeutic efficacy in gastrointestinal stromal tumor TS Kim, MJ Cavnar, NA Cohen, EC Sorenson, JB Greer, AM Seifert, ... Clinical Cancer Research 20 (9), 2350-2362, 2014 | 57 | 2014 |
| Wnt/β-catenin signaling contributes to tumor malignancy and is targetable in gastrointestinal stromal tumor S Zeng, AM Seifert, JQ Zhang, MJ Cavnar, TS Kim, VP Balachandran, ... Molecular cancer therapeutics 16 (9), 1954-1966, 2017 | 48 | 2017 |
| Genome and transcriptome profiling of fibrolamellar hepatocellular carcinoma demonstrates p53 and IGF2BP1 dysregulation EC Sorenson, R Khanin, ZM Bamboat, MJ Cavnar, TS Kim, E Sadot, ... PloS one 12 (5), e0176562, 2017 | 39 | 2017 |
| Neoadjuvant therapy induces a potent immune response to sarcoma, dominated by myeloid and B cells PH Goff, L Riolobos, BJ LaFleur, MB Spraker, YD Seo, KS Smythe, ... Clinical Cancer Research 28 (8), 1701-1711, 2022 | 30 | 2022 |
Venu G. PillarisettyProfessor of Surgery, University of WashingtonПотвърден имейл адрес: uw.edu
